1.The controlled substances listed in this section are included in schedule IV.
2.Schedule IV consists of the drugs and other substances, by whatever official name,
common or usual name, chemical name, or brand name designated, listed in this
section.
3.Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation containing any of the following narcotic
drugs or their salts calculated as the free anhydrous base or alkaloid, in limited
quantities as set forth below:
a.Not more than 1 milligram of difenoxin and not less than 25 micrograms of
atropine sulfate per dosage unit.
b.Dextropropoxyphene (also known as alpha-(+)-4-dimethylamino- 1,2-diphenyl-3-
methyl-2-propionoxybutane).
c. 2-[(dimethylamino)methyl]-1-(3-met
Free access — add to your briefcase to read the full text and ask questions with AI
1. The controlled substances listed in this section are included in schedule IV.
2. Schedule IV consists of the drugs and other substances, by whatever official name,
common or usual name, chemical name, or brand name designated, listed in this
section.
3. Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation containing any of the following narcotic
drugs or their salts calculated as the free anhydrous base or alkaloid, in limited
quantities as set forth below:
a. Not more than 1 milligram of difenoxin and not less than 25 micrograms of
atropine sulfate per dosage unit.
b. Dextropropoxyphene (also known as alpha-(+)-4-dimethylamino- 1,2-diphenyl-3-
methyl-2-propionoxybutane).
c. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and
geometric isomers and salts of these isomers including Tramadol.
4. Depressants. Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation containing any quantity of the following
substances, including their salts, isomers, and salts of isomers whenever the
existence of those salts, isomers, and salts of isomers is possible within the specific
chemical designation:
a. Alprazolam.
b. Alfaxalone.
c. Barbital.
d. Brexanolone.
e. Bromazepam.
f. Camazepam.
g. Carisoprodol.
h. Chloral betaine.
i. Chloral hydrate.
j. Chlordiazepoxide.
k. Clobazam.
l. Clonazepam.
m. Clorazepate.
n. Clotiazepam.
o. Cloxazolam.
p. Daridorexant.
q. Delorazepam.
r. Diazepam.
s. Dichloralphenazone.
t. Estazolam.
u. Ethchlorvynol.
v. Ethinamate.
w. Ethyl loflazepate.
x. Fludiazepam.
y. Flunitrazepam.
z. Flurazepam.
aa. Fospropofol.
bb. Halazepam.
cc. Haloxazolam.
dd. Indiplon.
ee. Ketazolam.
ff. Lemborexant.
gg. Loprazolam.
hh. Lorazepam.
ii. Lorcaserin.
jj. Lormetazepam.
kk. Mebutamate.
ll. Medazepam.
mm. Meprobamate.
nn. Methohexital.
oo. Methylphenobarbital (also known as mephobarbital).
pp. Midazolam.
qq. Nimetazepam.
rr. Nitrazepam.
ss. Nordiazepam.
tt. Oxazepam.
uu. Oxazolam.
vv. Paraldehyde.
ww. Petrichloral.
xx. Phenobarbital.
yy. Pinazepam.
zz. Propofol.
aaa. Prazepam.
bbb. Quazepam.
ccc. Remimazolam.
ddd. Suvorexant.
eee. Temazepam.
fff. Tetrazepam.
ggg. Triazolam.
hhh. Zaleplon.
iii. Zolpidem.
jjj. Zopiclone.
kkk. Zuranolone.
5. Stimulants. Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation which contains any quantity of the
following substances having a stimulant effect on the central nervous system, including
its salts, isomers, and salts of isomers:
a. Cathine.
b. Diethylpropion.
c. Fencamfamin.
d. Fenproporex.
e. Mazindol.
f. Mefenorex.
g. Modafinil.
h. Pemoline (including organometallic complexes and chelates thereof).
i. Phentermine.
j. Pipradrol.
k. Serdexmethylphenidate.
l. Sibutramine.
m. Solriamfetol.
n. SPA ((-)-1-dimethylamino-1, 2-diphenylethane).
6. Other substances. Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture, or preparation which contains any quantity of:
a. Pentazocine, including its salts.
b. Butorphanol, including its optical isomers.
c. Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-
oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-
methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and
salts of isomers.
7. Hallucinogenic substances. Pharmaceutical composition of crystalline polymorph
psilocybin, known as COMP360 or any such trade name approved for COMP360 by
the United States food and drug administration.
8. The board may except by rule any compound, mixture, or preparation containing any
depressant substance listed in subsection 2 from the application of all or any part of
this chapter if the compound, mixture, or preparation contains one or more active
medicinal ingredients not having a depressant effect on the central nervous system,
and if the admixtures are included therein in combinations, quantity, proportion, or
concentration that vitiate the potential for abuse of the substances which have a
depressant effect on the central nervous system.